Induction of inhibitory antibodies to the CCR5 chemokine receptor and their complementary role in preventing SIV infection in macaques

European Journal of Immunology

Volumn 29, Issue 8, 1999, Pages 2427-2435

  Lehner, Thomas ^a,c   Wang, Yufei ^a   Doyle, Carl ^a   Tao, Louisa ^a   Bergmeier, Lesley A ^a   Mitchell, Elaine ^a   Bogers, Willy M J M ^b   Heeney, Jonathan ^b   Kelly, Charles G ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antibody; CCR5; Primate; Simian immunodeficiency virus; Vaccine

Indexed keywords

CHEMOKINE RECEPTOR CCR5; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; EMBRYO; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNIZATION; MACACA; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTION; VIRUS INHIBITION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY FORMATION; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CHEMOTAXIS, LEUKOCYTE; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN G; MACACA MULATTA; RECEPTORS, CCR5; RECEPTORS, HIV; RECEPTORS, VIRUS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TRANSFECTION; VIRUS REPLICATION;

EID: 0032767534     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199908)29:08<2427::AID-IMMU2427>3.0.CO;2-5     Document Type: Article

References (39)

1. Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Marzio, P. D., Marmon, S., Sutton, R. E., Hill, C. M., Davis, C. B., Peiper, S. C., Schall, T. J., Littman, D. R. and Landau, N. R., Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996. 381: 661-666.
2. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996. 381: 667-673.
3. Chen, Z., Zhou, P., Ho, D. D., Landau, N. R. and Marx, P. A., Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J. Virol. 1997. 71: 2705-2714.
4. Edinger, A. L., Amedee, A., Miller, K., Doranz, B. J., Endres, M., Sharron, M., Samson, M., Lu, Z. H., Clements, J. E., Murphey-Corb, M. and Peiper, S. C., Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strain. Proc. Natl. Acad. Sci. USA 1997. 94: 4005-4010.
5. Hill, C. M., Deng, H. K., Unutmaz, D., Kewalramani, V. N., Bastiani, L., Gorny, M. K., Zolla-Pazner, S. and Littman, D. R., Envelope glycoproteins from HIV-1, HIV-2 and SIV can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor. J. Virol. 1997. 71: 6296-6304.
6. Lui, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A. and Landau, N. R., Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 1996. 86: 367-377.
7. Samson, M., Libert, F., Doranz, B. J., Rucker, J. and Liesnard, C., Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene. Nature 1996. 382: 722-725.
8. Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Smith, M. W., Allikmets, R., Goedert, J. J., Buchbinder, S. P., Vittinghoff, E., Gomperts, E., Donfield, S., Vlahov, D., Kaslow, R., Saah, A., Rinaldo, C., Detels, R. and O'Brien, S. J., Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Sience 1996. 273: 1856-1862.
9. Amara, A., Le. Gall, S., Schwartz, O., Salamera, J., Montes, M., Loetscher, P., Baggiolini, M., Virelizier, J.-L. and Arenzana-Seisdedos, F., HIV coreceptor down-regulation as antiviral principle: SDF-1a-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J. Exp. Med. 1997. 186: 136-146.
10. Desrosiers, R. C., Wyand, M. S., Kodama, T., Ringler, D. J., Arthur, L. O., Sehgal, P. K., Letvin, N. L., King, N. W. and Daniel, M. D., Vaccine protection against simian immunodeficiency virus infection. Proc. Natl. Acad. Sci. USA 1989. 8: 6353-6357.
11. Murphey-Corb, M., Martin, L. N., Davison-Fairburo, B., Montelaro, R. C., Miller M., West, M., Ohkawa, S., Baskin, G. B., Zhang, J. Y. and Putney, S. D., A formalin-inactivated whole SIV vaccine confers protection in macaques. Science 1989. 246: 1293-1297.
12. Carlson, J. R., McGraw, T. P., Keddie, E., Yee, J. L. Rosenthal, A., Langlois, A. J., Dickover, R., Donovan, R., Luciw, P. A. and Jennings, M. B., Vaccine protection of rhesus macaques against simian immunodeficiency virus infection. AIDS Res. Hum. Retroviruses 1990. 6: 1239-1246.
13. Stott, E. J., Chan, W. L., Mills, K. H., Page, M., Taffs, F., Cranage, M., Greenaway, P. and Kitchin, P., Preliminary report: protection of cynomolgus macaques against simian immunodeficiency viurus by whole fixed cell vaccine. Lancet 1990. 336: 1538-1541.
14. Stott, E. J., Kitchin, P. A., Page, M., Flanagen, B., Taffs, L. F., Chen, W. L., Mills, K. H. G., Silvera, P. and Rodgere, A., Anti-cell antibody in macaques. Nature 1991. 353: 393.
15. Langlois, A. J., Weinhold, K. J., Matthews, T. J., Greenberg, M. L. and Bolognesi, D. P., The ability of certain SIV vaccines to provoke reactions against normal cells. Science 1992. 255: 292-293.
16. Arthur, L. O., Bess, J. W., Jr., Sowder II, R. C., Benveniste, R. E., Mann, D. L., Chermann, J. C. and Henderson, L. E., Cellular proteins bound to immunodeficiency viruses: implications for pathogensis and vaccines. Science 1992. 258: 1935-1938.
17. Chan, W. L., Rodgers, A., Hancock, R. D., Taffs, F., Kitchin, P., Farrar, G. and Liew, F. Y., Protection of simian immunodeficiency virus-vaccinated monkeys correlates with anti-HLA class I antibody response. J. Exp. Med. 1992. 176: 1203-1207.
18. Cranage, M. P., Polyanskaya, N., McBride, B., Cook, N., Ashworth, L. A., Dennis, M., Baskerville, A., Greenaway, P. J., Corcoran, T. and Kitchin, P., Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 1993. 9: 13-22.
19. Bergmeier, L. A., Walker, J., Tao, L., Cranage, M. and Lehner, T. Antibodies to human and non-human primate cellular and culture medium components in macaques vaccinated with the simian immunodeficiency virus. Immunology 1994. 83: 213-220.
20. Hoxie, J. A., Fitzharris, T. P., Youngbar, P. R., Matthew, S. D. M., Rackowski, J. L. and Radka, S. F., Nonrandom association of cellular antigens with HTLV-III virions. Hum. Immunol. 1987. 18: 39-52.
21. Henderson, L. E., Sowder, R. and Copeland, T., Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III. J. Viol. 1987. 61: 629-632.
22. Wang, Y., Tao, L., Mitchell, E., Bogers, W. M. J. M., Doyle, C. Bravery, C. A., Bergmeier, L. A., Kelly, C. G., Heeney, J. L. and Lehner, T., Generation of CD8-SF and β chemokines induced by xenogeneic immunisation in the prevention of SIV infection in macaques. Proc. Natl. Acad. Sci. USA 1998. 95: 5223-5228.
23. Lehner, T., Wang, Y., Bravery, C. A., Doyle, C., Mitchell, E., Bogers, W., Raport C., Schweickart, V., Wood, C., Gray, P., Bergmeier, L. A., Tao, L., Kelly, C. G. and Heeney, J. L., Antibodies to CCR5 receptors and β chemokines, generated by xenogeneic immunization, in the prevention of SIV infection in macaques. Abstract. NCVGD meeting, NIH, Bethesda, May 1997.
24. Osterhaus, A., de Vries, P. and Heeney, J., AIDS vaccine developments. Nature 1992. 355: 684-685.
25. LeGrand, R., Vaslin, B., Vogt, G., Roques, P., Dormont, D. and Aubertin, A. M., AIDS vaccine developments. Nature 1992. 355: 684.
26. Cranage, M. P., Ashworth, L. A. E., Greenaway, P. J., Murphey-Corb, M. and Desrosiers, R. C., AIDS Vaccine Developments. Nature 1992. 355: 685-686.
27. Deng, H., Unutmaz, D., Kewal Ramani, V. N. and Littman, D., Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 1997. 388: 296-300.
28. Farzan, M., Choe, H., Martin, K., Marcon, L., Hofmann, W., Karlsson, G., Sun, Y., Barrett, P., Marchand, N., Sullivan, N., Gerard, N., Gerard, C. and Sodroski, J., Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J. Exp. Med. 1997. 186: 405-411.
29. Fu, L.-X., Magnusson, Y., Bergh, C. H., Liljeqvist, J. A., Waagstein, F., Hjalmarson, A. and Hoebeke, J., Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J. Clin. Invest. 1993. 91: 1964-1968.
30. Fu, M. L. X., Herlitz, H., Wallukat, G., Hilme, E., Hedner, T., Hoebeke, J. and Hjalmarson, A., Functional autoimmune epitope on α1-adrenergic receptors in patients with malignant hypertension. Lancet 1994. 344: 1660-1663.
31. Ditzel, H. J., Rosenkilde, M. M., Garred, P., Wang, M., Koefoed, K., Pedersen, C., Burton, D. R. and Schwartz, T. W., The CCR5 receptor acts as an alloantigen in CCR5Δ32 homozygous individuals: Identification of chemokine- and HIV-1 blocking human antibodies. Proc. Natl. Acad. Sci. USA 1998. 95: 5241-5245.
32. Edinger, A. L., Adaemee, A., Miller, K., Doranz, B. J., Endress, M., Sharron, M., Samson, M., Lu, Z.-H., Clements, J. E., Murphey-Corb, M., Peiper, S. C., Parmentier, M., Broder, C. C. and Doms, R. W., Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proc. Natl. Acad. Sci. USA 1997. 94: 4005-4010.
33. Zagury, D., Bernard, J., Leibowitch, J., Safai, B., Groopman, J. E., Feldman, M., Sarngadharan, M. G. and Gallo, R. C., HTLV-III in cells cultured from semen of two patients with AIDS. Science 1984. 226: 449-451.
34. Shearer, G. M., Clerici, M. and Dalgleish, A., Alloimmunization as an AIDS Vaccine? Science 1993. 262: 161-162.
35. Clerici, M., Shearer, G., Hounsell, E. F., Jameson, B., Habeshaw, J. and Dalgleish, A. G., Alloactivated cytotoxic T cells recognize the carboxy-terminal domain of human immunodeficiency virus-1 gp120 envelope glycoprotein. Eur. J. Immunol. 1993. 23: 2022-2025.
36. Doyle, C. B., Bhattacharyya, U., Kent, K. A., Stott, J. E. and Jones I. M., Regions required for CD4 binding in the external glycoprotein gp120 of simian immunodeficiency virus. J. Virol. 1995. 69: 1256-1260.
37. Raport, C. J., Gosling, J., Schweickart, V. L., Gray, P. W. and Charo, I. F., Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta and MIP-1alpha. J. Biol. Chem. 1996. 271: 17161-17166.
38. Heeney, J. L., van Els, C., de Vries, P., ten Haaft, P., Otting, N., Koornstra, W., Boes, J., Dubbes, R., Niphuis, H., Dings, M., Cranage, M., Norley, S., Jonker, M., Bontrop, R. E. and Osterhaus, A., Major histocompatibility complex class-I associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells. J. Exp. Med. 1994. 180: 769-774.
39. Bleul, C., Fuhlbrigge, R., Casasnovas, J., Aiuti, A. and Springer, T., A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 1996. 184: 1101-1109.